Novel PCSK9 inhibitor lowers LDL-c in another large phase 3 study
Evan Stein, MD, PhD
Causal relationship between elevated Lp(a) levels and CKD risk
Anne Langsted, MD, PhD
Encouraging data with APOC3 siRNA in mixed hyperlipidemia
Christie Ballantyne, MD
Rationale for dietary fat recommendations in ASCVD prevention
Jacob J. Christensen, PhD
Loading...
We’re glad to see you’re enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.
